FDA requests an additional $500M in user fees from industry to add staff and expand capabilities

The FDA's device arm is hoping to secure an additional $500 million in user fees over 5 years via the reauthorization of the fourth Medical Device User Fee Act. The agency proposed adding 20 employees to establish a quality management team, about 50 to review regulatory submissions and 15 to evaluate postmarket data. But first it needs to get the backing of the industry, which will foot the bill for the increased efforts via additional user fees. More

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.